474 — Aceso Life Science Balance Sheet

0.000.00%

Last trade - 00:00

IndustrialsHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for Aceso Life Science, fiscal year end - March 31st, HKD millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	C2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	786	717	602	469	212
Net Total Accounts Receivable
Net Total Receivables	756	1,065	744	762	294
Total Inventory
Total Other Current Assets
Total Current Assets	2,026	2,266	1,945	1,265	530
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	291	283	262	234	172
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	6,165	6,263	6,301	4,786	3,243
Accounts Payable
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	1,096	2,451	2,855	2,214	1,906
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	3,783	4,261	4,752	3,865	3,231
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	2,382	2,002	1,549	921	12
Total Liabilities & Shareholders' Equity	6,165	6,263	6,301	4,786	3,243
Total Common Shares Outstanding